Search results
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowen
ETF DAILY NEWS· 5 hours agoRegeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lifted by TD Cowen from $1,020.00 to $1,030.00 in a research report issued to clients and investors ...
Regeneron (REGN) Reports Next Week: What You Should Expect
Zacks via Yahoo Finance· 20 hours agoRegeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via AOL· 23 hours agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Regeneron Pharmaceuticals is upping its investment in genetic medicine, announcing Thursday a $100 million deal with CRISPR drug developer...
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 22 hours agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Regeneron and Mammoth Biosciences team up on gene editing By Investing.com
Investing.com· 15 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) and Mammoth Biosciences have announced a...
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 21 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
JD Supra: Regeneron v Novartis and Vetter: Walker Process Client Update
JD Supra· 14 hours agoIn an appeal that attracted a dozen amici, including the Department of Justice, the Federal Trade Commission, five states, and the District of Columbia, the Second Circuit gave the Walker Process ...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters via AOL· 21 hours agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a...
Regeneron signs Mammoth gene editing deal worth $100M upfront
FierceBiotech· 21 hours agoRegeneron is signing another major deal in gene editing—and, this time, it’s Mammoth. Mammoth...